Comparative effects of canagliflozin and sitagliptin in chronically ischemic myocardium.
Sharif A SabeDwight D HarrisMark BroadwinCynthia M XuMohamed SabraDebolina BanerjeeM Ruhul AbidFrank W Sellke
Published in: Vessel plus (2024)
In the setting of chronic myocardial ischemia, canagliflozin is associated with improved cardiac function compared to sitagliptin, with similar effects on perfusion despite differences in microvascular collateralization.